The Ty Louis Campbell Foundation (TLC), a non-profit organization that funds pediatric research, will host its fifth annual gala, a masquerade-themed fundraiser to benefit childhood cancer research on Saturday, March 9, 2019, at the Hyatt Regency Greenwich in Greenwich, CT from 7PM – Midnight.
This year’s “Masquerade Gala” will kick off with a cocktail hour followed by a 3-course dinner, five-hour open bar, music by NYCE Productions, dancing, live and silent auctions, casino tables, and entertainment.
During the Gala’s cocktail hour, attendees will have the opportunity to bid in the Gala’s Purse-onality auction featuring handbags filled stuffed to the top with just about anything a person might need. The silent auction will include a wide range of priceless experiences such as VIP access to the Macy’s Day Parade, concert tickets, sports outings, memorabilia, getaways and much more.
In addition to the evening’s festivities, the Gala will include a special award presentation to honoree Lori Pfiefer, who will receive the TLC “Heart of Gold” award for her exemplary efforts in supporting pediatric cancer research.
“Our annual gala is TLC’s largest adult-centered fundraising event of the year with 100% of the proceeds going directly to funding new research treatments for children who are currently battling aggressive cancers,” said Cindy Campbell, co-founder of the Ty Louis Campbell Foundation. “Donating an auction item, becoming a Gala sponsor or purchasing a ticket will greatly impact TLC in its ability to fund urgently needed therapies and treatment options for children who desperately need them now.”
In keeping with the Gala’s festive masquerade theme, attendees are encouraged but not required to wear masquerade masks; however, cocktail attire is required.
For more information on ticket and sponsorship opportunities, please visit thetlcfoundation.org or call 845-200-7486.
About Ty Louis Campbell Foundation (TLC)
The Ty Louis Campbell Foundation is a nonprofit organization that funds innovative research and clinical trials specifically geared toward the treatment of the most aggressive childhood cancers. Its mission is to help fund the intelligence and technology that will improve long-term survival rates and minimize side-effects for children diagnosed with the deadliest cancers, while helping to care for families when their child is in treatment by providing financial assistance and uplifting experiences.